Explore: Adverse Effects [mesh]

thought to be treatment-related. Spontaneous reports to the U.S. FDA Adverse Effects Reporting System at the time of the 20 September 2011 U.S. FDA Pediatric

The elderly are at an increased risk of both short- and long-term adverse effects, and as a result, all benzodiazepines are listed in the Beers List

adverse effect. Adverse effects are sometimes referred to as "iatrogenic" because they are generated by a physician/treatment. Some adverse effects occur

natriuretic, but this effect disappears with chronic consumption. The main adverse effects of diuretics are hypovolemia, hypokalemia, hyperkalemia, hyponatremia

because side effects can be beneficial as well as detrimental. The study of ADRs is the concern of the field known as pharmacovigilance. An adverse event (AE)

associated with severe side effects including organ perforation, infection, and pain. Safety and efficacy of many newer meshes is unknown. Thousands of class

escalating actions to deal with the growing adverse effects and low repair efficacy of transvaginal mesh for POP repair. In 2011, it issued an FDA Safety

can be used with MeSH terms to more completely describe a particular aspect of a subject, such as adverse, diagnostic or genetic effects. For example, the

general anesthesia. Immediately following treatment, the most common adverse effects are confusion and transient memory loss. Among treatments for severely

risk of stroke. Both drug classes appear to have comparable rates of adverse effects as other antihypertensives such as angiotensin II receptor blockers